New Study Links Immune Cells to Alzheimer's Risk
最新研究將免疫細胞與阿茲海默症風險聯繫起來
Recent scientific breakthroughs have fundamentally changed our understanding of Alzheimer's disease (AD).
最近的科學突破從根本上改變了我們對阿茲海默症(AD)的認知。
Once seen primarily as a buildup of toxic proteins, researchers now recognize AD as a complex disorder of the brain's immune system.
過去人們主要將其視為有毒蛋白質的堆積，如今研究人員已認識到AD是一種腦部免疫系統的複雜障礙。
Microglia, the brain's resident defenders, act as a double-edged sword.
小膠質細胞是大腦的常駐衛士，牠們宛如雙刃劍。
While they normally clear harmful debris, chronic activation causes them to release toxic substances that damage healthy neurons.
雖然牠們通常負責清除有害碎屑，但慢性激活會導致其釋放損傷健康神經元的毒素。
Furthermore, recent studies highlight that peripheral cells, such as T cells and neutrophils, can infiltrate the brain when the blood-brain barrier weakens, worsening inflammation.
此外，最近的研究突顯出外周細胞(如T細胞和嗜中性球)在血腦屏障減弱時會浸潤大腦，加劇炎症。
Even more striking is the discovery that microglia can accumulate genetic mutations over time, rendering them dysfunctional.
更驚人的是，科學家發現小膠質細胞隨時間推移會累積基因突變，導致其功能失調。
The STING pathway, which triggers inflammation in response to DNA damage, further highlights how the brain's defense mechanism can turn against itself.
STING途徑會針對DNA損傷引發炎症，進一步凸顯了大腦的防禦機制如何轉而攻擊自身。
These findings are revolutionary, moving medical focus toward precision immunotherapy.
這些發現是革命性的，將醫學焦點推向精準免疫療法。
Instead of only targeting protein plaques, scientists are now testing ways to 're-educate' immune cells and using simple blood tests to predict dementia risk years before symptoms appear.
科學家現在不再單一鎖定蛋白斑塊，而是在測試如何「再教育」免疫細胞，並利用簡單的血液檢測在症狀出現前數年預測失智症的風險。
